Is BMY or HCA cheaper?

On trailing earnings, HCA is cheaper: BMY trades at a 15.80 P/E and HCA at 13.65.

Which has grown faster, BMY or HCA?

Over the past five years, HCA grew revenue faster — BMY at a 2.52% CAGR versus HCA at 7.73%.

Does BMY or HCA pay a bigger dividend?

BMY yields 4.45% and HCA yields 0.76% based on trailing dividends and the latest price.

Is BMY or HCA more profitable?

BMY runs the higher net margin — BMY at 15.01% versus HCA at 8.89%.

Which has been the better investment, BMY or HCA?

Over the past 10-year, HCA delivered the higher annualized total return — BMY at 1.00% versus HCA at 18.63%. Past performance doesn't predict future results.

Bristol-Myers Squibb Company (BMY) vs HCA Healthcare, Inc. (HCA)

HCA leads on 9 of 16 compared metrics.

A side-by-side comparison of Bristol-Myers Squibb Company and HCA Healthcare, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 16, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

BMY

Bristol-Myers Squibb Company

Total return — BMY vs HCA

growth of $100 · last 15y

BMY +113.2%HCA +1179.6%HCA compounded faster

Log scale — wide-divergence pair

BMY HCA

BMY vs HCA: by the numbers

•BMY is the larger company ($114.38B vs $88.05B market cap).
•HCA trades at the lower earnings multiple (13.65 vs 15.80 P/E).
•BMY converts more revenue to profit (15.01% vs 8.89% net margin).
•HCA grew revenue faster over the past five years (7.73% vs 2.52% CAGR).
•BMY pays the higher dividend yield (4.45% vs 0.76%).

Which is better, BMY or HCA?

Metric tally: BMY 7 · HCA 9

It depends on what you're optimizing for:

ValueHCA(lower P/E)

GrowthHCA(faster 5Y revenue CAGR)

IncomeBMY(higher dividend yield)

QualityHCA(higher ROIC)

Metrics side by side

Valuation

Metric	BMY	HCA
P/E ratio	15.80	13.65●
Forward P/E	9.17●	11.96
P/S ratio	2.37	1.18●
P/B ratio	5.73	—
PEG ratio	1.68	0.56●
EV / EBITDA	10.90	8.86●
FCF yield	10.36%●	8.81%

Profitability

Metric	BMY	HCA
Gross margin	68.75%●	34.92%
Operating margin	25.67%●	15.67%
Net margin	15.01%●	8.89%
ROE	36.25%●	-112.56%
ROIC	13.90%	18.53%●

Dividends

Metric	BMY	HCA
Dividend yield	4.45%●	0.76%
Payout ratio	72.25%	10.48%

Growth (annualized)

Metric	BMY	HCA
Revenue CAGR (5Y)	2.52%	7.73%●
EPS CAGR (5Y)	9.38%	20.90%●
FCF CAGR (5Y)	-2.50%	1.92%●
Total return CAGR (5Y)	0.46%	14.89%●

Frequently asked

Which is better, BMY or HCA?: It depends on your goal. value: HCA (lower P/E); growth: HCA (faster 5Y revenue CAGR); income: BMY (higher dividend yield); quality: HCA (higher ROIC). Across all compared metrics, HCA leads 9 to 7.
Is BMY or HCA cheaper?: On trailing earnings, HCA is cheaper: BMY trades at a 15.80 P/E and HCA at 13.65.
Which has grown faster, BMY or HCA?: Over the past five years, HCA grew revenue faster — BMY at a 2.52% CAGR versus HCA at 7.73%.
Does BMY or HCA pay a bigger dividend?: BMY yields 4.45% and HCA yields 0.76% based on trailing dividends and the latest price.
Is BMY or HCA more profitable?: BMY runs the higher net margin — BMY at 15.01% versus HCA at 8.89%.
Which has been the better investment, BMY or HCA?: Over the past 10-year, HCA delivered the higher annualized total return — BMY at 1.00% versus HCA at 18.63%. Past performance doesn't predict future results.

Go deeper

Full BMY analysis Full HCA analysis Interactive comparison tool

Dig into the metrics

Bristol-Myers Squibb P/E ratio HCA Healthcare P/E ratio Bristol-Myers Squibb dividend yield HCA Healthcare dividend yield Bristol-Myers Squibb ROE HCA Healthcare ROE Bristol-Myers Squibb operating margin HCA Healthcare operating margin Bristol-Myers Squibb revenue growth HCA Healthcare revenue growth Bristol-Myers Squibb free cash flow HCA Healthcare free cash flow

Bristol-Myers Squibb & HCA Healthcare appear in these rankings

Highest Dividend Yield Stocks Highest ROE Stocks Highest ROIC Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 16, 2026.